Listed

Beam Therapeutics Inc.

BEAMNasdaqCIK 1745999HealthcareFiscal year ends Dec 31

Reports and events: 110 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Beam Therapeutics Inc., Reports and events
FiledFormWhat it isAccession number
2023-10-1908:50 ET8-K2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-258963
2023-08-0807:30 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-039364
2023-08-0807:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-039356
2023-06-0816:31 ET8-K5.07 Shareholder vote results0000950170-23-027026
2023-05-1016:56 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-140832
2023-05-1007:31 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-020090
2023-05-1007:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-020063
2023-04-2116:06 ETDEF 14AProxy statement0000950170-23-013837
2023-02-2807:31 ET10-KAnnual reportPeriod 2022-12-310000950170-23-004866
2023-02-2807:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-004858
2023-01-0907:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-004131
2022-11-0707:31 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-022322
2022-11-0707:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-022313
2022-09-0706:47 ET8-K8.01 Other events0000950170-22-018147
2022-08-3007:08 ET8-K8.01 Other events0000950170-22-017868
2022-08-0907:31 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-015755
2022-08-0907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-015736
2022-08-0106:50 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-013559
2022-06-1016:57 ET8-K5.07 Shareholder vote results0000950170-22-011501
2022-05-0907:33 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008238
2022-05-0907:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-008231
2022-04-2216:24 ETDEF 14AProxy statementPeriod 2022-06-080000950170-22-006016
2022-02-2807:31 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002166
2022-02-2807:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-002162
2022-01-1006:45 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-000163
2021-11-0808:31 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003317
2021-11-0806:19 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-21-003291
2021-08-1007:46 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-001110
2021-08-1006:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-001108
2021-07-0716:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-209865
2021-06-1116:10 ET8-K5.07 Shareholder vote results0001564590-21-032654
2021-05-2416:10 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-029509
2021-05-1116:16 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-026555
2021-05-1107:48 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-026294
2021-04-2316:10 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-020341
2021-04-2316:05 ETDEF 14AProxy statementPeriod 2021-06-090001564590-21-020335
2021-04-0107:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-103255
2021-03-1517:01 ET10-KAnnual reportPeriod 2020-12-310001564590-21-013190
2021-03-1506:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-012996
2021-02-2308:43 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-051599
2021-01-1906:46 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-010753
2021-01-1318:11 ET8-K7.01 Regulation FD disclosure0001564590-21-001028
2021-01-1207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-000920
2021-01-1116:30 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-000861
2020-11-1006:49 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-052723
2020-11-1006:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-052718
2020-09-2816:02 ETS-1Registration statement0001193125-20-256298
2020-08-1207:45 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-039490
2020-08-1207:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-039482
2020-06-2909:28 ET8-K7.01 Regulation FD disclosure0000950123-20-006470

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:58 ET. Listed shows no prices and gives no investment advice.